BioCardia's market cap is currently ―. The company's EPS TTM is $-0.548; its P/E ratio is -0.69; BioCardia is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 357.00K	$ 43.00K	$ 64.00K	$ 106.00K	$ 212.00K
Gross Profit	$ 357.00K	$ 43.00K	-	-	-
EBIT	$ -2.57M	$ -3.42M	$ 3.65M	$ -3.02M	$ -3.06M
EBITDA	$ -2.47M	$ -3.32M	$ 3.75M	$ -2.92M	$ -3.03M
Net Income Common Stockholders	$ -2.57M	$ -3.42M	$ 3.65M	$ -3.03M	$ -3.06M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.83M	$ 4.30M	$ 4.86M	$ 7.36M	$ 6.67M
Total Assets	$ 3.75M	$ 6.39M	$ 7.13M	$ 9.79M	$ 9.18M
Total Debt	$ 1.40M	$ 1.48M	$ 1.55M	$ 1.63M	$ 1.70M
Net Debt	$ -437.00K	$ -2.83M	$ -3.30M	$ -5.73M	$ -4.96M
Total Liabilities	$ 4.41M	$ 4.75M	$ 5.23M	$ 4.90M	$ 5.08M
Stockholders Equity	$ -660.00K	$ 1.64M	$ 1.90M	$ 4.89M	$ 4.10M
Cash Flow	-
Free Cash Flow	$ -2.41M	$ -3.15M	$ -2.57M	$ -3.00M	$ -2.02M
Operating Cash Flow	$ -2.41M	$ -3.15M	$ -2.56M	$ -3.00M	$ -2.01M
Investing Cash Flow	-	$ -2.00K	$ -10.00K	$ -2.00K	$ -14.00K
Financing Cash Flow	$ -58.00K	$ 2.60M	$ 64.00K	$ 3.69M	$ 73.00K

Currency in USD

BioCardia Earnings and Revenue History

Income Statement >

BioCardia Debt to Assets

Balance Sheet >

BioCardia Cash Flow

Cash Flow >

BioCardia Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing